Prostate carcinoma

Gerald L. Andriole; William J. Catalona

doi:10.1146/annurev.med.45.1.351

Prostate carcinoma

Gerald L. Andriole, William J. Catalona

Research output: Contribution to journal › Review article › peer-review

9 Scopus citations

Abstract

Over the last several years, the development of prostate-specific antigen (PSA) testing and technical refinements of anatomic radical prostatectomy have revolutionized the care of patients with prostate cancer. Serum PSA testing often allows early diagnosis of organ-confined prostate cancer. Anatomical radical prostatectomy has a high probability of completely eradicating these tumors, with minimal long-term morbidity. Use of PSA testing after therapy confirms the long-term ability of surgery to eradicate early-stage prostate cancer.

Original language	English
Pages (from-to)	351-359
Number of pages	9
Journal	Annual review of medicine
Volume	45
DOIs	https://doi.org/10.1146/annurev.med.45.1.351
State	Published - May 25 1994

Keywords

digital rectal examination (DRE) screening
prostate-specific antigen (PSA)
transrectal ultrasound (TRUS)

Access to Document

10.1146/annurev.med.45.1.351

Cite this

@article{8b003acffb2f4718ba0f0c69cd4d01df,

title = "Prostate carcinoma",

abstract = "Over the last several years, the development of prostate-specific antigen (PSA) testing and technical refinements of anatomic radical prostatectomy have revolutionized the care of patients with prostate cancer. Serum PSA testing often allows early diagnosis of organ-confined prostate cancer. Anatomical radical prostatectomy has a high probability of completely eradicating these tumors, with minimal long-term morbidity. Use of PSA testing after therapy confirms the long-term ability of surgery to eradicate early-stage prostate cancer.",

keywords = "digital rectal examination (DRE) screening, prostate-specific antigen (PSA), transrectal ultrasound (TRUS)",

author = "Andriole, {Gerald L.} and Catalona, {William J.}",

year = "1994",

month = may,

day = "25",

doi = "10.1146/annurev.med.45.1.351",

language = "English",

volume = "45",

pages = "351--359",

journal = "Annual review of medicine",

issn = "0066-4219",

}

TY - JOUR

T1 - Prostate carcinoma

AU - Andriole, Gerald L.

AU - Catalona, William J.

PY - 1994/5/25

Y1 - 1994/5/25

N2 - Over the last several years, the development of prostate-specific antigen (PSA) testing and technical refinements of anatomic radical prostatectomy have revolutionized the care of patients with prostate cancer. Serum PSA testing often allows early diagnosis of organ-confined prostate cancer. Anatomical radical prostatectomy has a high probability of completely eradicating these tumors, with minimal long-term morbidity. Use of PSA testing after therapy confirms the long-term ability of surgery to eradicate early-stage prostate cancer.

AB - Over the last several years, the development of prostate-specific antigen (PSA) testing and technical refinements of anatomic radical prostatectomy have revolutionized the care of patients with prostate cancer. Serum PSA testing often allows early diagnosis of organ-confined prostate cancer. Anatomical radical prostatectomy has a high probability of completely eradicating these tumors, with minimal long-term morbidity. Use of PSA testing after therapy confirms the long-term ability of surgery to eradicate early-stage prostate cancer.

KW - digital rectal examination (DRE) screening

KW - prostate-specific antigen (PSA)

KW - transrectal ultrasound (TRUS)

UR - http://www.scopus.com/inward/record.url?scp=0028244187&partnerID=8YFLogxK

U2 - 10.1146/annurev.med.45.1.351

DO - 10.1146/annurev.med.45.1.351

M3 - Review article

C2 - 7515219

AN - SCOPUS:0028244187

SN - 0066-4219

VL - 45

SP - 351

EP - 359

JO - Annual review of medicine

JF - Annual review of medicine

ER -

Prostate carcinoma

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this